Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study
- PMID: 29496481
- DOI: 10.1016/j.jaad.2018.02.049
Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study
Comment in
-
Thalidomide and thromboprophylaxis for dermatologic indications: An unmet need for more evidence.J Am Acad Dermatol. 2018 Sep;79(3):e45-e46. doi: 10.1016/j.jaad.2018.04.048. Epub 2018 May 4. J Am Acad Dermatol. 2018. PMID: 29733936 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources